Shopping Cart
Remove All
Your shopping cart is currently empty
Stamulumab (Synonyms: MYO-029, MYO029)
Catalog No. T76993 Copy Product Info
Purity: 95%
🥰Excellent
Stamulumab (MYO-029) is a high-affinity recombinant human antibody and myostatin neutralising antibody capable of increasing muscle mass in SCID mice. It may be employed in studying various muscular dystrophies, such as BMD, FSHD, and LGMD.
Stamulumab
Copy Product Info🥰Excellent
Catalog No. T76993
Synonyms MYO-029, MYO029
Stamulumab (MYO-029) is a high-affinity recombinant human antibody and myostatin neutralising antibody capable of increasing muscle mass in SCID mice. It may be employed in studying various muscular dystrophies, such as BMD, FSHD, and LGMD.
Stamulumab
Cas No. 705287-60-1
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $199 | - | In Stock | |
| 5 mg | $513 | - | In Stock | |
| 10 mg | $818 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:96.7% (SDS-PAGE); 99.1% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Stamulumab (MYO-029) is a high-affinity recombinant human antibody and myostatin neutralising antibody capable of increasing muscle mass in SCID mice. It may be employed in studying various muscular dystrophies, such as BMD, FSHD, and LGMD. |
| In vivo | Method: Stamulumab (1-10 mg/kg/week, 12 weeks) was administered intraperitoneally to female SCID mice to evaluate its efficacy. Results: Stamulumab dose-dependently increased skeletal muscle mass, with an Emax value of 23%-30% and a Cave50 range of 47-72 nM. [1] |
| Synonyms | MYO-029, MYO029 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | GDF8/Myostatin |
| Molecular Weight | 142.80 kDa |
| Cas No. | 705287-60-1 |
| Isotype | Human IgG1 lambda2 |
| Recommended Isotype Control |
| Storage | Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
Preview
Related Tags: buy Stamulumab | purchase Stamulumab | Stamulumab cost | order Stamulumab | Stamulumab in vivo | Stamulumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.